Brigatinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso CAS No:NA chemically represented as N-(5-Chloro-4-((2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso . We supply Brigatinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142868 |
| CAS No | NA |
| Mol.F. | C21H20N4O5 |
| Mol.Wt. | 408.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142869 |
| CAS No | NA |
| Mol.F. | C21H22N4O6 |
| Mol.Wt. | 426.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142870 |
| CAS No | 52322-22-2 |
| Mol.F. | C10H22N4O4 |
| Mol.Wt. | 262.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142871 |
| CAS No | 78213-39-5 |
| Mol.F. | C10H23N3O3 |
| Mol.Wt. | 233.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142872 |
| CAS No | NA |
| Mol.F. | C10H23N3O3 |
| Mol.Wt. | 233.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142873 |
| CAS No | NA |
| Mol.F. | C10H19N3O5 |
| Mol.Wt. | 261.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142874 |
| CAS No | NA |
| Mol.F. | C17H25F3N4O2 |
| Mol.Wt. | 374.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142875 |
| CAS No | NA |
| Mol.F. | C17H24F3N3O2 |
| Mol.Wt. | 359.39g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142876 |
| CAS No | NA |
| Mol.F. | C19H22F3N3O6 |
| Mol.Wt. | 445.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142877 |
| CAS No | NA |
| Mol.F. | C20H28F3N3O5 |
| Mol.Wt. | 447.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142878 |
| CAS No | NA |
| Mol.F. | C16H18F3N3O5 |
| Mol.Wt. | 389.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142879 |
| CAS No | NA |
| Mol.F. | C16H23F3N4O3 |
| Mol.Wt. | 376.38 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142880 |
| CAS No | NA |
| Mol.F. | C15H22F3N3O4 |
| Mol.Wt. | 365.35g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142881 |
| CAS No | NA |
| Mol.F. | C19H22F3N3O6 |
| Mol.Wt. | 445.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142882 |
| CAS No | NA |
| Mol.F. | C17H20N2O5 |
| Mol.Wt. | 332.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142883 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |